Clinical potential of serum prostaglandin A2 as a novel diagnostic biomarker for hepatocellular cancer
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Prostaglandin A2 (PGA2) shows promise as a novel biomarker for early hepatocellular cancer (HCC) detection. This study confirms PGA2
Area Of Science
- Biomarker Discovery
- Hepatocellular Carcinoma (HCC) Research
- Metabolomics
Background
- Hepatocellular cancer (HCC) poses a significant global health threat.
- Current diagnostic methods lack sufficient sensitivity and specificity for early HCC detection.
- There is an unmet need for reliable biomarkers for early HCC diagnosis.
Purpose Of The Study
- To investigate the diagnostic potential of Prostaglandin A2 (PGA2) for early hepatocellular cancer (HCC) detection.
- To establish and validate a quantitative method for serum PGA2 measurement in HCC patients.
Main Methods
- Untargeted metabolomic analysis was performed on discovery and validation cohorts.
- A liquid chromatography-tandem mass spectrometry (LC-MS/MS) method was developed and validated for serum PGA2 quantification.
- Statistical analyses, including ROC and DCA, were used to evaluate diagnostic performance.
Main Results
- Serum PGA2 levels were found to be significantly decreased in HCC patients compared to control and cirrhosis groups.
- PGA2 demonstrated high diagnostic accuracy for HCC (AUC=0.911), including small-size, early-stage, and AFP-negative HCC.
- The combination of PGA2 and AFP may enhance HCC surveillance and early diagnosis in at-risk populations.
Conclusions
- Prostaglandin A2 (PGA2) is identified as a potential novel diagnostic biomarker for hepatocellular cancer (HCC).
- PGA2 shows significant potential for the early detection of HCC, even in challenging subgroups.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
